Gregory Durm

10PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsLiquid biopsiesSocial and community informatics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1.

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.

Sonam Puri, Natasha B Leighl, Nofisat Ismaila

|Oct 23, 2025
A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancer.

Hirva Mamdani, Ryan D Gentzler, Lin Gu

|Jul 15, 2025
Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081.

Greg Durm, Hirva Mamdani, Sandra Althouse

|Feb 27, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3.

Natasha B Leighl, Nofisat Ismaila, Greg Durm

Pageof 2

Frequent Collaborators

4 joint publications

Lyudmila Bazhenova

4 joint publications

Natasha B Leighl

4 joint publications

Nofisat Ismaila

4 joint publications

Janet Freeman-Daily